Cargando…
Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: An experimental murine model
BACKGROUND: Respiratory syncytial virus (RSV) is the leading respiratory viral pathogen in young children worldwide. RSV disease is associated with acute airway obstruction (AO), long-term airway hyperresponsiveness (AHR), and chronic lung inflammation. Using two different mouse strains, this study...
Autores principales: | Chávez-Bueno, Susana, Mejías, Asunción, Gómez, Ana M, Olsen, Kurt D, Ríos, Ana M, Fonseca-Aten, Mónica, Ramilo, Octavio, Jafri, Hasan S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1183251/ https://www.ncbi.nlm.nih.gov/pubmed/15916706 http://dx.doi.org/10.1186/1743-422X-2-46 |
Ejemplares similares
-
Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008) -
2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019) -
The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines
por: King, Tiffany, et al.
Publicado: (2021) -
79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)